STAR — Strides Pharma Science Share News
0.000.00%
Last trade - 00:00- IN₹93.54bn
- IN₹107.43bn
- IN₹48.59bn
Brief: Strides Pharma Science Unit Strides Gets A$94 Million As Deferred Consideration For Sale Of Australian Operations In 2019
Strides Pharma rises on USFDA nod for Potassium Chloride Oral Solution
Brief: Strides Pharma Science Receives USFDA Approval For Potassium Chloride Oral Solution
Brief: India's Strides Pharma Science Reports Sept-Quarter Consol Net Profit
Brief: Strides Pharma Science Unit Receives Positive Recommendation From European Medicines Agency
India's Strides Pharma Science sees best day in over a week
Brief: Strides Pharma Science Gets U.S. FDA Approval For Naproxen Sodium OTC Softgel Capsules
Brief: Strides Pharma Science Says FDA Inspection Of Singapore Facility Completed With Zero Observations
Brief: India's Strides Pharma Science June-Qtr Consol Net Loss Narrows
Brief: Strides Pharma Science Approves Fund Raise Via Non-Convertible Debentures Up To 1.50 Bln Rupees
Brief: Strides Pharma Science To Consider Fund Raise Via Non-Convertible Debentures
Brief: Strides Pharma Science Says Biolexis, Akston Biosciences Announce Encouraging Top-Line Results From Phase II/III Trial Of Thermostable COVID-19 Vaccine
Brief: Strides Pharma Says Stelis Biopharma's Two Biologics Manufacturing Facilities Get EU CGMP Accreditation
Brief: Strides Pharma Science Gets U.S. FDA Approval For Ibuprofen Otc Oral Suspension
Brief: Strides Pharma Science Gets U.S. FDA Approval For Ibuprofen Oral Suspension
Refinitiv Newscasts - WEF panel discusses opportunities and challenges 1
R. Ananthanarayanan Quits As MD, CEO
Akston Biosciences And Biolexis Collaborate To Launch A Room Temperature Stable 2Nd Generation Covid-19 Vaccine
Brief: Akston Biosciences And Biolexis Collaborate To Launch A Room Temperature Stable 2Nd Generation Covid-19 Vaccine In 130+ Countries